Life Science Investing Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
Life Science Investing Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Life Science Investing CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
Life Science Investing Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
Life Science Investing Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare's SRT Combined with Punch Excision to Treat Keloids
